The measure addresses adherence to three types of chronic medications: statins, levothyroxine, and angiotensin converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs). The measure is divided into three submeasures:
Measure A: The percentage of eligible individuals who had at least two prescriptions for statins and who have a Proportion of Days Covered (PDC) of at least 0.8 during the measurement period (12 consecutive months).
Measure B: The percentage of eligible individuals who had at least two prescriptions for levothyroxine and who have a PDC of at least 0.8 during the measurement period (12 consecutive months).
Measure C: The percentage of eligible individuals who had at least two prescriptions for ACEIs/ARBs and who have a PDC of at least 0.8 during the measurement period (12 consecutive months).
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisNumerator
Numerator A: Individuals with at least two prescriptions for statins having a PDC of at least 0.8.
Numerator B: Individuals with at least two prescriptions for levothyroxine having a PDC of at least 0.8.
Numerator C: Individuals with at least two prescriptions for ACEIs/ARBs having a PDC of at least 0.8.DenominatorDenominator A: Individuals with at least two prescriptions for statins.
Denominator B: Individuals with at least two prescriptions for levothyroxine.
Denominator C: Individuals with at least two prescriptions for ACEIs/ARBs.ExclusionsNot Applicable
Testing Data Sources
- Measure StructureNon Condition SpecificTarget PopulationNational Quality Strategy PrioritiesEffective Communication and Care Coordination
- Risk Adjustment
- Current or planned use(s)
- Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Patient Safety Project 2013-2014Initial EndorsementEndorsement StatusLast UpdatedRemoval Date
- Steward Organization Email